News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Hirawat Samit
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/05/2023 |
4
| Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) has filed a Form 4 on BRISTOL MYERS SQUIBB CO
Txns:
| Paid exercise price by delivering 4,787 shares
@ $63.95, valued at
$306.1k
Exercised 9,357 restricted stock units
@ $0 |
|
03/14/2023 |
4
| Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) has filed a Form 4 on BRISTOL MYERS SQUIBB CO
Txns:
| Acquired 775 shares
@ $0 Paid exercise price by delivering 2,540 shares
@ $65.71, valued at
$166.9k
Acquired 802 shares
@ $0 Paid exercise price by delivering 2,909 shares
@ $65.71, valued at
$191.2k
Acquired 154 shares
@ $0 Paid exercise price by delivering 2,517 shares
@ $65.71, valued at
$165.4k
Acquired 3,069 shares
@ $0 Paid exercise price by delivering 14,429 shares
@ $65.71, valued at
$948.1k
Exercised 4,189 options to buy
@ $0 Exercised 4,885 options to buy
@ $0 Exercised 4,765 options to buy
@ $0 |
|
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/12/2021 |
4
| Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) has filed a Form 4 on BRISTOL MYERS SQUIBB CO
Txns:
| Acquired 78 shares
@ $0 Paid exercise price by delivering 1,978 shares
@ $60.93, valued at
$120.5k
Exercised 4,189 options to buy
@ $0 Granted 19,541 options to buy
@ $0 Granted 29,311 options to buy
@ $0 |
|
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/12/2020 |
4
| Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) has filed a Form 4 on BRISTOL MYERS SQUIBB CO
Txns:
| Granted 16,759 options to buy
@ $0 Granted 25,139 options to buy
@ $0 |
|
07/03/2019 |
4
| Hirawat Samit (Chief Medical Offr., Drug Dev.) has filed a Form 4 on BRISTOL MYERS SQUIBB CO
Txns:
| Granted 37,425 restricted stock units
@ $0 |
|
07/01/2019 |
3
| Hirawat Samit (Chief Medical Offr., Drug Dev.) has filed a Form 3 on BRISTOL MYERS SQUIBB CO |
|
|